Vinpocetine during pregnancy: FDA warns of safety risk

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2019年 / 1757卷 / 1期

关键词：

D O I：

10.1007/s40278-019-63236-0

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：8 / 8

相关论文

共 50 条

[1] Antipsychotics a risk to neonates during pregnancy warns FDA
[J]. Reactions Weekly, 2011, 1341 (1) : 2 - 2
[2] FDA warns of seizure risk with dalfampridine
[J]. Reactions Weekly, 2012, 1412 (1) : 2 - 2
[3] Antidepressants: FDA warns of paediatric suicide risk
[J]. Reactions Weekly, 2003, 976 (1) : 2 - 2
[4] FDA WARNS OF RISK FROM HORMONE PRODUCTS
不详
[J]. JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 2018, 253 (08): : 949 - 949
[5] FDA warns of risk of peripheral neuropathy with fluoroquinolones
[J]. Reactions Weekly, 2013, 1466 (1) : 2 - 2
[6] FDA warns of risks associated with the use of antipsychotic medications in pregnancy
不详
[J]. FORMULARY, 2011, 46 (04) : 147 - 147
[7] Risk of differentiation syndrome with enasidenib, warns US FDA
[J]. Reactions Weekly, 2018, 1732 (1) : 4 - 4
[8] FDA warns of risk of intrathecal injection of tranexamic acid
[J]. Reactions Weekly, 2020, 1835 (1) : 1 - 1
[9] US FDA warns of increased myopathy risk with Zocor
[J]. Reactions Weekly, 2010, 1294 (1) : 1 - 1
[10] FDA warns of potential risk from donor tissues
Fox, Steven
[J]. INFECTIONS IN MEDICINE, 2006, 23 (10) : 458 - 458

← 1 2 3 4 5 →